Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK)

CUSIP: 86150R107

Q3 2025 13F Holders as of 30 Sep 2025

Holder snapshot 7 signals
Share change
+2,134,051
Put/Call ratio
18%
SEC-reported price per share
$23.50
Number of holders
151
Value change
+$64,324,837
Number of buys
83
Open additional details 1 more signal available
Number of sells
62
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
58,810,778

Security key

86150R107

Report period

Q3 2025

Institutions

151

Top holders

10

Ownership snapshot

Top reported holders of STOK - Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G 13F 3/4/5 Lead comparable stake: 6.8% 13D/G row: BlackRock, Inc. Showing 1-6 of 15 holder rows.

Quick read

BlackRock, Inc. leads the comparable SEC ownership view at 6.8%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership Top 5
BlackRock, Inc. 6.8%
MORGAN STANLEY 6.5%
BlackRock Portfolio Management LLC 4.7%
Skorpios Trust 4.1%
FMR LLC 13%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock, Inc.
13D/G 13F
Company
6.8%
$87,769,558
3,732,540 shares
+$14,428,761 30 Sep 2025
MORGAN STANLEY
13F 13D/G
Company
6.5%
from 13D/G
$40,564,628
3,573,976 shares
30 Jun 2025
BlackRock Portfolio Management LLC
13D/G
4.7%
$28,946,115
2,550,341 shares
-$2,192,358 30 Jun 2025
Skorpios Trust
3/4/5 13D/G 13F
10%+ Owner · Montrago Trustees Ltd · Company
4.1%
from 13D/G
$39,843,046
3,906,181 shares
04 Jun 2025
FMR LLC
13F
Company
13F
13%
$84,137,345
7,412,982 shares
30 Jun 2025
Lynx1 Capital Management LP
13F
Company
13F
9.2%
$61,343,050
5,404,674 shares
30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
151
Shares
67,691,438
Rows available
151
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
133
Q3 2025 holders
151
Holder diff
18
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 value Q3 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .